Combined synopsis and solicitation
Abbott Molecular m2000 Viral Load Supplies
2026-Q-97958
Centers for Disease Control and Prevention, CDC Office of Acquisition Services. Analytical Laboratory Instrument Manufacturing.
Response deadline
July 28, 2026 at 4:00 PM EDT
Closed 50 days ago. Posted July 23, 2026. Scheduled to archive August 12, 2026.
Description
As published on SAM.gov.
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) International Laboratory Branch intends to award a firm-fixed price, sole source purchase order to Abbott Molecular, Inc., 1350 E Touhy Avenue, Suite 300, West Des Plains, Illinois 60018 for the purchase of Maintenance Services for the Abbott m2000. The authority for this sole source acquisition is in accordance with FAR Part 5.203 and FAR Part 12.102(a).
Abbott Molecular, Corporation is currently the only company that possess proprietary manufacturing processes and maintenance of their equipment; thus the only authorized service provider for the Abbott m2000 equipment. Any services provided from other sources will void any warranties or guarantees and may forfeit services by Abbott Molecular equipment if requested.
Accordingly, because this is the instrument that the lab currently uses and requires for their work, no other retailer can provide the required maintenance, repairs, replacements and/or services of the equipment. As a result of this synopsis, a separate solicitation is not required and will not be posted on sam.gov.
However, responsible sources that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by the closing date of this posting. The Contracting Officer will not respond to verbal request. All requests must be in writing. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer.
Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall be sent to Debra Baker by email at xvv9@cdc.gov and reference solicitation #2026-Q-98331 on the subject line.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 23, 2026
Combined synopsis and solicitation
Due July 28, 2026 at 4:00 PM EDT. SAM.gov, notice ad28771f204440acb271396f3b5f449d
Points of contact
- Debra Bakerxvv9@cdc.gov
- Liubov Krielvyh1@cdc.gov
Also open from this buyer
- FY27-28 Pediatric Flu VaccinesCombined synopsis and solicitationNAICS 325412Georgia75D30126R73518Closes todaySep 16
- FY27-28 Adult Flu VaccinesCombined synopsis and solicitationNAICS 325412Georgia75D30126R73517Closes todaySep 16
- Notice Of Intent to Sole Source - Bruker Scientific, LLC - DART JS Ion Source System with High Throughput Sampling (HTS)PresolicitationNAICS 334516Ohio099087Closes todaySep 16
- Notice Of Intent to Sole Source - Thermo Fisher Scientific Asheville LLC - Centrifuge CalibrationPresolicitationNAICS 811210West Virginia98976Closes todaySep 16
- (Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEPPresolicitationNAICS 621511GeorgiaPR97866Closes tomorrowSep 17